MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1

CUSIP: 590328AA8

Q3 2013 13F Holders as of 30 Sep 2013

Type / Class
Debt / NOTE 4.500% 7/1
Market price (% of par)
90.46%
Total 13F principal
$14,000,000
Principal change
+$9,000,000
Total reported market value
$12,663,000
Number of holders
2
Value change
+$8,138,000
Number of buys
1

Quarterly Holders Quick Answers

What is CUSIP 590328AA8?
CUSIP 590328AA8 identifies 590328AA8 - MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 as of Q3 2013

As of 30 Sep 2013, MERRIMACK PHARMACEUTICALS IN - NOTE 4.500% 7/1 was held by 2 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $14,000,000 in principal (par value) of the bond. The largest 2 bondholders included Citadel Advisors LLC and LAZARD ASSET MANAGEMENT LLC. This page lists 2 institutional bondholders reporting positions for the Q3 2013 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.